Allergan is to market Anika Therapeutics' CoEase product under a three-year deal. The product is hyaluronic acid-based viscoelastic product for use in ophthalmic surgery, including cataract and intraocular lens implantation. Allergan will assign the agreement to Advanced Medical Optics (AMO), its medical device unit that is due to be spun off to form an independent company (see Clinica No 1007, p 20)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?